Pharma channel feed

New Jer­sey's bait worked: Af­ter promise of $40M in in­cen­tives, Te­va is mov­ing its HQ

7 years ago

Trump in­vites phar­ma heads to pri­vate din­ner dur­ing Lon­don vis­it, a trip that's in­spir­ing tens of thou­sands to protest

7 years ago
People

What's BIO and PhRMA do­ing to ad­dress sex­u­al ha­rass­ment? Sen­a­tor Mur­ray wants to know

7 years ago

Af­ter clos­ing the gap on new hires, FDA could face an ex­o­dus of top reg­u­la­tors

7 years ago
R&D

Ac­ne was a bust, but ex­ces­sive sweat­ing scores FDA OK for Der­mi­ra — shares climb

8 years ago

How does the first half of 2018 mea­sure up against the last 7 years for biotech IPOs?

8 years ago
Financing

Three years lat­er the FDA fi­nal­ly lifts its hold on Ap­tose drug, set­ting the stage for a re­turn to PhIb

8 years ago

Bio­gen goes deep in­to biosim­i­lars, slap­ping down $700M for a ma­jor stake in Sam­sung Bioepis

8 years ago
R&D

Sar­co­ma ex­pert George Demetri grades the lat­est state­ment on Nanobi­otix's late-stage drug NBTXR3

8 years ago
People
R&D

C-Bridge hands Nu­ance Biotech $35M, open­ing doors to more Chi­na li­cens­ing deals

8 years ago
Financing
R&D

Ar­ray wres­tles FDA OK for its MEK/BRAF melanoma com­bo, to hit the phar­ma­cy as Mek­tovi and Braftovi

8 years ago

Roivant un­der­goes ma­jor re­struc­tur­ing, cut­ting and shift­ing its staff

8 years ago
Startups
R&D

CHMP re­vers­es course on ner­a­tinib, hand­ing Puma an un­ex­pect­ed win on Eu­ro­pean mar­ket­ing vote — shares soar

8 years ago

Achao­gen hits, then miss­es: FDA OKs Zem­dri for cUTIs, but re­jects sec­ond in­di­ca­tion

8 years ago

A mon­ster dis­cov­ery deal be­tween Ab­b­Vie and Google’s Cal­i­co gets a new lease on the lab, with $1B more to back ag­ing re­search

8 years ago

FDA to re­lease list of sur­ro­gate end­points in on­col­o­gy

8 years ago

FDA OKs first cannabi­noid, gives green light to GW Phar­ma’s Epid­i­olex for rare seizures

8 years ago

A slim­mer FDA: White House pro­pos­es 30% cut to head­count un­der re­or­ga­ni­za­tion

8 years ago

Bris­tol-My­ers clears an­oth­er hur­dle in Mer­ck lung can­cer show­down — but big chal­lenges re­main

8 years ago

J&J opens up a new biotech in­cu­ba­tor, pol­ish­ing the Big Ap­ple's am­bi­tions to cre­ate a ma­jor hub

8 years ago
Startups
R&D

Ex-Puma ex­ec sen­tenced to prison stretch on in­sid­er-trad­ing con­vic­tion — 'greed' made me do it

8 years ago
People

No­vo takes on gut-brain ax­is dis­cov­ery with Kally­ope, fo­cus­ing on obe­si­ty and di­a­betes

8 years ago
R&D

Roche bags full con­trol of Foun­da­tion Med­i­cine in $2.4B fol­low-up buy­out

8 years ago
Deals

Valeant nose­dives on CRL for plaque pso­ri­a­sis, rais­ing con­cerns over tout­ed $1B pipeline

8 years ago
R&D
First page Previous page 300301302303304305306 Next page Last page
A service from the Financial Times